Today, I talk breast cancer and how Odonate’s oral Taxane (Tesataxel) could garner the attention of doctor’s looking to alleviate the burden of IV chemotherapy infusion in their patients. I discuss the latest macro news, biotech news, and compare previous Taxane revenue to see if my model is reasonable.
This is not investment advice, but for entertainment purposes. I am not liable for any losses you generate from trading.
Could you please send the model? This video was very helpful and informative!
LikeLike
Here you go: https://drive.google.com/drive/folders/1d2pu56ITturPHtgGtSnRZcl0EHe0kqe9?usp=sharing
LikeLike